Low genitourinary tract risks in women living with the human immunodeficiency virus

References

• UNAIDS. 20.2 million girls and women living with HIV; [cited 2023 Jan 12]. Available from:https://www.unaids.org/en/resources/infographics/girls-and-women-living-with-HIV.
   Google Scholar
• Trickey A, May MT, Vehreschild JJ, et al. Survival of HIV-positive patients starting antiretroviral therapy between 1996 and 2013: a collaborative analysis of cohort studies. Lancet HIV. 2017;4(8):e349–e356.
   PubMed Web of Science ®Google Scholar
• Saag MS, Gandhi RT, Hoy JF, et al. Antiretroviral drugs for treatment and prevention of HIV infection in adults: 2020 recommendations of the international antiviral society-USA panel. JAMA. 2020;324(16):1651–1669.
   PubMed Web of Science ®Google Scholar
• Andany N, Kennedy VL, Aden M, et al. Perspectives on menopause and women with HIV. Int J Womens Health. 2016;8:1–22.
   PubMed Web of Science ®Google Scholar
• Centers for Disease, Control and Prevention: Statistics overview: HIV Surveillance Report. New HIV diagnoses in the US and dependent areas by age at diagnosis, 2020; [cited 2023 Feb 21]. Available from: https://www.cdc.gov/hiv/statistics/overview/index.html.
   Google Scholar
• Gianella S, Rawlings SA, Dobrowolski C, et al. Sex differences in human immunodeficiency virus persistence and reservoir size during aging. Clin Infect Dis. 2022;75(1):73–80. doi:10.1093/cid/ciab873.
   PubMed Web of Science ®Google Scholar
• Massanella M, Bender Ignacio RA, Lama JR, et al. Long-term effects of early antiretroviral initiation on HIV reservoir markers: a longitudinal analysis of the MERLIN clinical study. Lancet Microbe. 2021;2(5):e198–e209. 5247(21)00010-0.
   Google Scholar
• Vieira-Baptista P, Marchitelli C, Haefner HK, et al. Deconstructing the genitourinary syndrome of menopause. Int Urogynecol J. 2017;28(5):675–679.
   PubMed Web of Science ®Google Scholar
• Spinillo A, Debiaggi M, Zara F, et al. Factors associated with nucleic acids related to human immunodeficiency virus type 1 in cervico-vaginal secretions. BJOG. 2001;108(6):634–641.
   PubMedGoogle Scholar
• Roberts L, Passmore JA, Mlisana K, et al. Genital tract inflammation during early HIV-1 infection predicts higher plasma viral load set point in women. J Infect Dis. 2012;205(2):194–203.
   PubMed Web of Science ®Google Scholar
• Gornalusse GG, Valdez R, Fenkart G, et al. Mechanisms of endogenous HIV-1 reactivation by endocervical epithelial cells. J Virol. 2020;94(9):e01904-19.
   PubMed Web of Science ®Google Scholar
• Nguyen PV, Kafka JK, Ferreira VH, et al. Innate and adaptive immune responses in male and female reproductive tracts in homeostasis and following HIV infection. Cell Mol Immunol. 2014;11(5):410–427.
   PubMed Web of Science ®Google Scholar
• Wessels JM, Felker AM, Dupont HA, et al. The relationship between sex hormones, the vaginal microbiome and immunity in HIV-1 susceptibility in women. Dis Model Mech. 2018;11(9):dmm035147.
   PubMed Web of Science ®Google Scholar
• Szotek EL, Narasipura SD, Al-Harthi L. 17β-Estradiol inhibits HIV-1 by inducing a complex formation between β-catenin and estrogen receptor α on the HIV promoter to suppress HIV transcription. Virology. 2013;443(2):375–383.
   PubMed Web of Science ®Google Scholar
• Masson L, Passmore JA, Liebenberg LJ, et al. Genital infammation and the risk of HIV acquisition in women. Clin Infect Dis. 2015;61(2):260–269.
   PubMed Web of Science ®Google Scholar
• Arnold KB, Burgener A, Birse K, et al. Increased levels of infammatory cytokines in the female reproductive tract are associated with altered expression of proteases, mucosal barrier proteins,and an infux of HIV-susceptible target cells. Mucosal Immunol. 2016;9(1):194–205.
   PubMed Web of Science ®Google Scholar
• Muhleisen AL, Herbst-Kralovetz MM. Menopause and the vaginal microbiome. Maturitas. 2016;91:42–50.
   PubMed Web of Science ®Google Scholar
• Ravel J, Gajer P, Abdo Z, et al. Vaginal microbiome of reproductive-age women. Proc Natl Acad Sci USA. 2011;108(Suppl 1):4680–4687.
   PubMed Web of Science ®Google Scholar
• De Seta F, Lonnee-Hoffmann R, Campisciano G, et al. The vaginal microbiome: III. The vaginal microbiome in various urogenital disorders. J Low Genit Tract Dis. 2022;26(1):85–92.
   PubMed Web of Science ®Google Scholar
• Armstrong E, Kaul R, Cohen CR. Optimizing the vaginal microbiome as a potential strategy to reduce heterosexual HIV transmission. J Intern Med. 2023;293(4):433–444.
   PubMed Web of Science ®Google Scholar
• Ñahui Palomino RA, Vanpouille C, Laghi L, et al. Extracellular vesicles from symbiotic vaginal lactobacilli inhibit HIV-1 infection of human tissues. Nat Commun. 2019;10(1):5656.
   PubMedGoogle Scholar
• Shardell M, Gravitt PE, Burke AE, et al. Association of vaginal microbiota with signs and symptoms of the genitourinary syndrome of menopause across reproductive stages. J Gerontol A Biol Sci Med Sci. 2021;76(9):1542–1550.
   PubMed Web of Science ®Google Scholar
• Verstraelen H, Vieira-Baptista P, De Seta F, et al. The vaginal microbiome: I. Research development, lexicon, defining ‘normal’ and the dynamics throughout women’s lives. J Low Genit Tract Dis. 2022;26(1):73–78.
   PubMed Web of Science ®Google Scholar
• Gosmann C, Anahtar MN, Handley SA, et al. Lactobacillus-deficient cervicovaginal bacterial communities are associated with increased HIV acquisition in young South African women. Immunity. 2017;46(1):29–37.
   PubMed Web of Science ®Google Scholar
• Nelson JAE, De Paris K, Ramirez C, et al. Female genital tract shedding of HIV-1 is rare in women with suppressed HIV-1 in plasma. AIDS. 2020;34(1):39–46.
   PubMed Web of Science ®Google Scholar
• Mudau M, Peters RP, De Vos L, et al. High prevalence of asymptomatic sexually transmitted infections among human immunodeficiency virus-infected pregnant women in a low-income South african community. Int J STD AIDS. 2018;29(4):324–333.
   PubMed Web of Science ®Google Scholar
• Murphy K, Keller MJ, Anastos K, et al. Impact of reproductive aging on the vaginal microbiome and soluble immune mediators in women living with and at-risk for HIV infection. PLoS One. 2019;14(4):e0216049.
   PubMed Web of Science ®Google Scholar
• Rao S. Sex differences in HIV-1 persistence and the implications for a cure. Front Glob Womens Health. 2022;3:942345.
   PubMedGoogle Scholar
• Harlow SD, Schuman P, Cohen M, et al. Effect of HIV infection on menstrual cycle length. J Acquir Immune Defic Syndr. 2000;24(1):68–75.
   PubMed Web of Science ®Google Scholar
• Yalamanchi S, Dobs A, Greenblatt RM. Gonadal function and reproductive health in women with human immunodeficiency virus infection. Endocrinol Metab Clin North Am. 2014;43(3):731–741.
   PubMed Web of Science ®Google Scholar
• Looby SE. Symptoms of menopause or symptoms of HIV? Untangling the knot. Menopause. 2018;25(7):728–730.
   PubMed Web of Science ®Google Scholar
• Fumaz CR, Muñoz-Moreno JA, Ferrer MJ, et al. Low levels of adherence to antiretroviral therapy in HIV-1-infected women with menstrual disorders. AIDS Patient Care STDS. 2009;23(6):463–468.
   PubMed Web of Science ®Google Scholar
• Valiaveettil C, Loutfy M, Kennedy VL, et al. High prevalence of abnormal menstruation among women living with HIV in Canada. PLoS One. 2019;14(12):e0226992.
   PubMed Web of Science ®Google Scholar
• Tempest N, Edirisinghe DN, Lane S, et al. Do women with HIV/AIDS on anti-retroviral therapy have a lower incidence of symptoms associated with menstrual dysfunction? Eur J Obstet Gynecol Reprod Biol. 2021;265:137–142.
   PubMed Web of Science ®Google Scholar
• Jalil EM, Domingues RM, Derrico M, et al. Evaluating the menopausal transition with the STRAW + 10 in a Brazilian cohort of women with HIV, 2015–2016. Climacteric. 2021;24(3):305–312.
   PubMed Web of Science ®Google Scholar
• Coburn SB, Dionne-Odom J, Alcaide ML, et al. The association between HIV status, estradiol, and sex hormone binding globulin among premenopausal women in the women’s interagency HIV study. J Womens Health. 2022;31(2):183–193.
   Web of Science ®Google Scholar
• Phillips SJ, Curtis KM, Polis CB. Effect of hormonal contraceptive methods on HIV disease progression: a systematic review. AIDS. 2013;27(5):787–794.
   PubMed Web of Science ®Google Scholar
• Murphy K, Irvin SC, Herold BC. Research gaps in defining the biological link between HIV risk and hormonal contraception. Am J Reprod Immunol. 2014;72(2):228–235.
   PubMed Web of Science ®Google Scholar
• Vitali D, Wessels JM, Kaushic C. Role of sex hormones and the vaginal microbiome in susceptibility and mucosal immunity to HIV-1 in the female genital tract. AIDS Res Ther. 2017;14(1):39.
   PubMedGoogle Scholar
• Hapgood JP, Kaushic C, Hel Z. Hormonal contraception and HIV-1 acquisition: biological mechanisms. Endocr Rev. 2018;39(1):36–78.
   PubMed Web of Science ®Google Scholar
• Cejtin HE, Kalinowski A, Bacchetti P, et al. Effects of human immunodeficiency virus on protracted amenorrhea and ovarian dysfunction. Obstet Gynecol. 2006;108(6):1423–1431.
   PubMed Web of Science ®Google Scholar
• Fan MD, Maslow BS, Santoro N, et al. HIV and the menopause. Menopause Int. 2008;14(4):163–168.
   PubMedGoogle Scholar
• Kanapathipillai R, Hickey M, Giles M. Human immunodeficiency virus and menopause. Menopause. 2013;20(9):983–990.
   PubMed Web of Science ®Google Scholar
• King EM, Albert AY, Murray MCM. HIV and amenorrhea: a meta-analysis. AIDS. 2019;33(3):483–491.
   PubMed Web of Science ®Google Scholar
• Andany N, Kaida A, de Pokomandy A, et al. Prevalence and correlates of early-onset menopause among women living with HIV in Canada. Menopause. 2020;27(1):66–75.
   PubMed Web of Science ®Google Scholar
• Hachfeld A, Atkinson A, Stute P, et al. Women with HIV transitioning through menopause: insights from the Swiss HIV Cohort Study (SHCS). HIV Med. 2022;23(4):417–425.
   PubMed Web of Science ®Google Scholar
• Schoenbaum EE, Hartel D, Lo Y, et al. HIV infection, drug use, and onset of natural menopause. Clin Infect Dis. 2005;41(10):1517–1524.
   PubMed Web of Science ®Google Scholar
• Dólleman M, Verschuren WM, Eijkemans MJ, et al. Added value of anti-Müllerian hormone in prediction of menopause: results from a large prospective cohort study. Hum Reprod. 2015;30(8):1974–1981.
   PubMed Web of Science ®Google Scholar
• Scherzer R, Bacchetti P, Messerlian G, et al. Impact of CD4+ lymphocytes and HIV infection on anti-Mullerian Hormone levels in a large cohort of HIV-infected and HIV-uninfected women. Am J Reprod Immunol. 2015;73(3):273–284.
   PubMed Web of Science ®Google Scholar
• Milic J, Guaraldi G. Hormone therapy in postmenopausal women living with HIV: a view towards prevention of multiple metabolic conditions and improvement of quality of life. AIDS. 2022;36(12):1731–1733.
   PubMed Web of Science ®Google Scholar
• Cvetkovic A, King E, Skerritt L, et al. A practical clinical guide to counselling on and managing contraception, pre-conception planning, and menopause for women living with HIV. J Assoc Med Microbiol Infect Dis Can. 2021;6(4):278–295.
   PubMedGoogle Scholar
• Suarez-García I, Alejos B, Pérez-Elías MJ, et al. How do women living with HIV experience menopause? Menopausal symptoms, anxiety and depression according to reproductive age in a multicenter cohort. BMC Womens Health. 2021;21(1):223.
   PubMed Web of Science ®Google Scholar
• Sookan T, Motala A, Ormsbee M, et al. Improvement in muscular strength in HIV-Infected individuals receiving antiretroviral therapy. J Funct Morphol Kinesiol. 2019;4(3):66.
   PubMedGoogle Scholar
• Jankowski CM, Mawhinney S, Wilson MP, et al. Body composition changes in response to moderate- or high-intensity exercise among older adults with or without HIV infection. J Acquir Immune Defic Syndr. 2020;85(3):340–345.
   PubMed Web of Science ®Google Scholar
• Sharma A, Hoover DR, Shi Q, et al. Human immunodeficiency virus (HIV) and menopause are independently associated with lower bone mineral density: results from the women’s interagency HIV study. Clin Infect Dis. 2022;75(1):65–72.
   PubMed Web of Science ®Google Scholar
• Walmsley S, Clarke R, Lee T, et al. BEING: bone health in aging women with HIV: Impact of switching antiretroviral therapy on bone mineral density during the perimenopausal period. AIDS Res Hum Retroviruses. 2023;2023:106.
   Google Scholar
• Hanna DB, Lin J, Post WS, et al. Association of macrophage inflammation biomarkers with progression of subclinical carotid artery atherosclerosis in HIV-Infected women and men. J Infect Dis. 2017;215(9):1352–1361.]
   PubMed Web of Science ®Google Scholar
• Peters BA, Hanna DB, Sharma A, et al. Menopausal hormone therapy and subclinical cardiovascular disease in women with and without human immunodeficiency virus. Clin Infect Dis. 2023;76(3):e661–e670.
   PubMedGoogle Scholar
• Mitchell KR, Geary R, Graham CA, et al. Painful sex (dyspareunia) in women: prevalence and associated factors in a british population probability survey. BJOG. 2017;124(11):1689–1697.
   PubMed Web of Science ®Google Scholar
• Valadares AL, Pinto-Neto AM, Gomes DC, et al. Dyspareunia in HIV-positive and HIV- negative middle-aged women: a cross-sectional study. BMJ Open. 2014;4(11):e004974.
   PubMedGoogle Scholar
• Johnson TM, Cohen HW, Howard AA, et al. Attribution of menopause symptoms in human immunodeficiency virus-infected or at-risk drug-using women. Menopause. 2008;15(3):551–557.
   PubMed Web of Science ®Google Scholar
• Boonyanurak P, Bunupuradah T, Wilawan K, et al. Age at menopause and menopause-related symptoms in human immunodeficiency virus-infected Thai women. Menopause. 2012;19(7):820–824.
   PubMed Web of Science ®Google Scholar
• Pérez-López FR, Vieira-Baptista P, Phillips N, et al. Clinical manifestations and evaluation of postmenopausal vulvovaginal atrophy. Gynecol Endocrinol. 2021;37(8):740–745.
   PubMed Web of Science ®Google Scholar
• Pérez-López FR, Phillips N, Vieira-Baptista P, et al. Management of postmenopausal vulvovaginal atrophy: recommendations of the international society for the study of vulvovaginal disease. Gynecol Endocrinol. 2021;37(8):746–752.
   PubMed Web of Science ®Google Scholar
• Denis A, Sung-Mook H. Sexual functioning of women with HIV: a comparison with non-HIV women. Canad J Hum Sexual. 2003;12(2):97–107.
   Google Scholar
• Luzi K, Guaraldi G, Murri R, et al. Body image is a major determinant of sexual dysfunction in stable HIV-infected women. Antivir Ther. 2009;14(1):85–92. Erratum in: antivir Ther. 2009;14(3):465.
   PubMed Web of Science ®Google Scholar
• Taylor TN, Munoz-Plaza CE, Goparaju L, et al. The pleasure is better as I’ve gotten older: sexual health, sexuality, and sexual risk behaviors among older women living with HIV. Arch Sex Behav. 2017;46(4):1137–1150.
   PubMed Web of Science ®Google Scholar
• Trotta MP, Ammassari A, Murri R, et al. Self-reported sexual dysfunction is frequent among HIV-infected persons and is assciated with suboptimal adherence to antiretrovirals. AIDS Patient Care STDS. 2008;22(4):291–299.
   PubMed Web of Science ®Google Scholar
• Toorabally N, Mercer CH, Mitchell KR, et al. Association of HIV status with sexual function in women aged 45–60 in England: results from two national surveys. AIDS Care. 2020;32(3):286–295.
   PubMed Web of Science ®Google Scholar
• Wilson TE, Jean-Louis G, Schwartz R, et al. HIV infection and women’s sexual functioning. J Acquir Immune Defic Syndr. 2010;54(4):360–367.
   PubMed Web of Science ®Google Scholar
• Muthiah B, Kallikadavil A, Shivaswamy R, et al. The study of gonadal hormonal abnormalities and sexual dysfunction in HIV positive females: an exploratory study. J Clin Diagn Res. 2016;10(4):OC11–OC14.
   PubMedGoogle Scholar
• Agaba PA, Meloni ST, Sule HM, et al. Sexual dysfunction and its determinants among women infected with HIV. Int J Gynaecol Obstet. 2017;137(3):301–308.
   PubMed Web of Science ®Google Scholar
• Mezones-Holguín E, Arriola-Montenegro J, Cutimanco-Pacheco V, et al. Low sexual function is associated with menopausal status in mid-aged women with human immunodeficiency virus infection. Menopause. 2022;29(3):317–326.
   PubMed Web of Science ®Google Scholar
• García-Abellán J, Del Río L, García JA, et al. Risk of cancer in HIV-infected patients in Spain, 2004-2015. The CoRIS cohort study. Enferm Infecc Microbiol Clin. 2019;37(8):502–508.
   Web of Science ®Google Scholar
• Orlando G, Bianchi S, Fasolo MM, et al. Cervical human papillomavirus genotypes in HIV-infected women: a cross-sectional analysis of the valhidate study. J Prev Med Hyg. 2017;58(4):E259–E265.
   PubMedGoogle Scholar
• Gupta R, Hussain S, Hariprasad R, et al. High prevalence of cervical high-grade lesions and high-risk human papillomavirus infections in women living with HIV: a case for prioritizing cervical screening in this vulnerable group. Acta Cytol. 2022;66(6):496–506.
   PubMed Web of Science ®Google Scholar
• Caicedo-Martínez M, Fernández-Deaza G, Ordóñez-Reyes C, et al. High-risk human papillomavirus infection among women living with HIV in latin america and the caribbean: a systematic review and meta-analysis. Int J STD AIDS. 2021;32(14):1278–1289.
   PubMed Web of Science ®Google Scholar
• Kelly H, Weiss HA, Benavente Y, et al. Association of antiretroviral therapy with high-risk human papillomavirus, cervical intraepithelial neoplasia, and invasive cervical cancer in women living with HIV: a systematic review and meta-analysis. Lancet HIV. 2018;5(1):e45–e58.
   PubMed Web of Science ®Google Scholar
• Stewart KA, Allen SM, Chesnokova AE, et al. Incidence of abnormal cervical and vaginal cytology among women over age 65 years living with human immunodeficiency virus. Am J Obstet Gynecol. 2020;222(5):486.e1–486.e10.
   PubMed Web of Science ®Google Scholar
• Klein KL, Goron AR, Taylor GH, et al. Pap smear outcomes in elderly women living with HIV and HIV-negative matched controls. Int J STD AIDS. 2022;33(11):954–962.
   PubMed Web of Science ®Google Scholar
• Lytvynenko M, Kachailo I, Lobashova K, et al. Cytological transformation of the cervix in immunodeficiency aggravated by alcoholism. Pol Merkur Lekarski. 2022;50(299):273–276.
   PubMedGoogle Scholar
• Wagner A, Skof AS, Sehouli J, et al. Genotype-specific high-risk human papillomavirus infections and risk factors for cervical dysplasia in women with human immunodeficiency virus in Germany: results from a single-center cross-sectional study. Int J Gynecol Cancer. 2022;32(6):716–723.
   PubMed Web of Science ®Google Scholar
• Lofgren SM, Tadros T, Herring-Bailey G, et al. Progression and regression of cervical pap test lesions in an urban AIDS clinic in the combined antiretroviral therapy era: a longitudinal, retrospective study. AIDS Res Hum Retroviruses. 2015;31(5):508–513.
   PubMed Web of Science ®Google Scholar
• Vieira-Baptista P, Pérez-López FR, López-Baena MT, et al. Risk of development of vulvar cancer in women with lichen sclerosus or lichen planus: a systematic review. J Low Genit Tract Dis. 2022;26(3):250–257.
   PubMed Web of Science ®Google Scholar
• Preti M, Joura E, Vieira-Baptista P, et al. The European society of gynaecological oncology (ESGO), the international society for the study of vulvovaginal disease (ISSVD), the European college for the study of vulval disease (ECSVD) and the european federation for colposcopy (EFC) consensus statements on pre-invasive vulvar lesions. J Low Genit Tract Dis. 2022;26(3):229–244.
   PubMed Web of Science ®Google Scholar
• WHO Classification of Tumours Editorial Board. Female genital tumours. 5th ed. Lyon; 2020. Available from: https://tumourclassification.iarc.who.int/chapters/34.
   Google Scholar
• Bradbury M, Xercavins N, García-Jiménez Á, et al. Vaginal intraepithelial neoplasia: clinical presentation, management, and outcomes in relation to HIV infection status. J Low Genit Tract Dis. 2019;23(1):7–12.
   PubMed Web of Science ®Google Scholar
• Shindel AW, Akhavan A, Sharlip ID. Urologic aspects of HIV infection. Med Clin North Am. 2011;95(1):129–151.
   PubMed Web of Science ®Google Scholar
• Larouche M, Albert AYK, Lipsky N, et al. Urinary symptoms and quality of life in women living with HIV: a cross-sectional study. Int Urogynecol J. 2021;32(2):353–358.
   PubMed Web of Science ®Google Scholar
• Breyer BN, Van den Eeden SK, Horberg MA, et al. HIV status is an independent risk factor for reporting lower urinary tract symptoms. J Urol. 2011;185(5):1710–1715.
   PubMed Web of Science ®Google Scholar
• Skrzat-Klapaczyńska A, Matłosz B, Bednarska A, et al. Factors associated with urinary tract infections among HIV-1 infected patients. PLoS One. 2018;13(1):e0190564.
   PubMed Web of Science ®Google Scholar
• Birhanu MY, Habtegiorgis SD, Gietaneh W, et al. Magnitude and associated factors of urinary tract infections among adults living with HIV in Ethiopia. Systematic review and meta-analysis. PLoS One. 2022;17(4):e0264732.
   PubMed Web of Science ®Google Scholar
• Omoregie R, Eghafona NO. Urinary tract infection among asymptomatic HIV patients in Benin city, Nigeria. Br J Biomed Sci. 2009;66(4):190–193.
   PubMed Web of Science ®Google Scholar
• Samje M, Yongwa O, Enekegbe AM, et al. Prevalence and antibiotic susceptibility pattern of bacteriuria among HIV-seropositive patients attending the Bamenda regional hospital, Cameroon. Afr Health Sci. 2020;20(3):1045–1052.
   PubMed Web of Science ®Google Scholar
• Miller SA, Santoro N, Lo Y, et al. Menopause symptoms in HIV-infected and drug-using women. Menopause. 2005;12(3):348–356.
   PubMed Web of Science ®Google Scholar
• Looby SE, Psaros C, Raggio G, et al. Association between HIV status and psychological symptoms in perimenopausal women. Menopause. 2018;25(6):648–656.
   PubMed Web of Science ®Google Scholar
• Cutimanco-Pacheco V, Arriola-Montenegro J, Mezones-Holguin E, et al. Menopausal symptoms are associated with non-adherence to highly active antiretroviral therapy in human immunodeficiency virus-infected Middle-aged women. Climacteric. 2020;23(3):229–236.
   PubMed Web of Science ®Google Scholar
• Solomon D, Sabin CA, Burns F, et al. The association between severe menopausal symptoms and engagement with HIV care and treatment in women living with HIV. AIDS Care. 2021;33(1):101–108.
   PubMed Web of Science ®Google Scholar